<DOC>
	<DOCNO>NCT00395070</DOCNO>
	<brief_summary>To compare safety efficacy Allovectin-7® versus Dacarbazine ( DTIC ) Temozolomide ( TMZ ) subject recurrent stage 3 stage 4 melanoma .</brief_summary>
	<brief_title>A Phase 3 Pivotal Trial Comparing Allovectin-7® Alone v Chemotherapy Alone Patients With Stage 3 Stage 4 Melanoma</brief_title>
	<detailed_description>Eligible patient 66 % chance receive Allovectin-7® alone ( investigational product design train body 's immune system recognize destroy tumor cell ) vs. 33 % chance receive standard chemotherapy ( either dacarbazine temozolomide ) . The treatment course recommend patient receive Allovectin-7® minimum 16 week . Each cycle consist weekly injection Allovectin-7® alone six week follow two week observation assessment . For patient receive chemotherapy alone , treatment course follow standard dosing . During trial patient ' tumor closely monitor . Patients whose melanoma clinically progress encouraged continue treatment assess two year .</detailed_description>
	<mesh_term>Melanoma</mesh_term>
	<mesh_term>Temozolomide</mesh_term>
	<mesh_term>Dacarbazine</mesh_term>
	<criteria>Inclusion Criteria ( Potential study participant must meet follow criterion ) : Confirmed Stage 3 Stage 4 melanoma may previous treatment via surgery , radiation biologic drug ( typically Interferon Alpha Interleukin2 ) At least 1 melanoma tumor 1cm x 1cm great size ( size dime ) inject Normal blood chemistry blood cell count At least 18 year old able willing provide inform consent participate Exclusion Criteria ( Potential study participant eligible follow ) : Previous chemotherapy treatment melanoma Melanoma lesion brain liver ( however , lesion lung allow ) If surgical removal lesion would possible could curative Any melanoma tumor great 10cm x 10cm size Known condition result suppress immune system Female subject pregnant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>Melanoma</keyword>
	<keyword>DTIC</keyword>
	<keyword>TMZ</keyword>
	<keyword>Stage 3</keyword>
	<keyword>Stage 4</keyword>
	<keyword>Metastatic</keyword>
	<keyword>Metastatic Melanoma ( Stage 3 , Stage 4 Melanoma )</keyword>
</DOC>